Following elective total hip replacement, both continuous lumbar plexus blockade and spinal anaesthesia (with adjunctive intrathecal morphine) have shown early outcome benefits over opioid analgesia and single-injection nerve block. However, the two techniques have not been compared in a prospective randomised manner. Our study examined 50 patients undergoing elective hip joint replacement who were randomised to receive spinal anaesthesia (with adjunctive intrathecal morphine 0.1 mg) or patient-controlled continuous lumbar plexus blockade. All surgery was conducted under general anaesthesia. Measured outcomes included numerically rated postoperative pain, supplemental opioid consumption and indices of mobilisation together with complications. Results show that block placement time was marginally shorter for the spinal group (5 versus 7 minutes, P=0.01). The primary outcome, worst pain on movement/mobilisation during the first 24 hours, was not statistically significantly different between groups. Patients in the lumbar plexus group were given more intraoperative opioid and rescue morphine in the post-anaesthesia care unit (median = 4 versus 0 mg, P <0.001), with correspondingly higher pain scores (median 5/10 versus 0/10, P <0.001). Pain scores during the subsequent 24 hours were similar between groups, but more patients in the spinal group were given rescue morphine (5 versus 0, P=0.02). Physiotherapy mobilisation indices appeared similar between groups. More spinal group patients reported pruritus (12 versus 5, P=0.01), but antiemetic requirements, episodes of disorientation, arterial oxygen desaturation and falls were all similar between groups. Postoperative symptoms suggestive of neurological irritation or injury did not differ between groups. We found that following elective hip joint replacement, compared to continuous lumbar plexus blockade, spinal anaesthesia incorporating adjunctive intrathecal morphine did not result in a statistically significant difference in worst pain on movement/mobilisation during the first 24 hours, although it was associated with better analgesia in the post-anaesthesia care unit. Subsequently, however, these patients appeared to require more rescue morphine and more of them reported pruritus.
Compared with systemic opioid-only analgesia, spinal anaesthesia (with intrathecal opioid) and continuous lumbar plexus blockade have both been shown to improve pain relief and patient satisfaction after total hip replacement [1] [2] [3] [4] [5] [6] [7] . However, no previous study has compared the two techniques in a prospective randomised manner.
We therefore conducted a prospective randomised controlled trial to compare spinal anaesthesia (with intrathecal morphine) with continuous lumbar plexus blockade for analgesia after hip replacement.
Methods
Local institutional review board approval was obtained (Northern Y Regional Ethics Committee, Hamilton, New Zealand; approval number NTY/09/03/029) and the trial was registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12609000316202, March 2009). We enrolled consecutive American Society of Anesthesiologists physical status 1 to 3 patients, scheduled for elective total hip arthroplasty in the principal investigator's practice at the Southern Cross Brightside Hospital. Exclusion criteria included spinal or lumbar plexus block refusal, spinal deformities likely to render subarachnoid block technically difficult, known amide local anaesthetic drug allergy, known neuropathy of the operative extremity, non-steroidal anti-inflammatory drug intolerance, and preoperative opioid therapy administered for >1 month before surgery. Approximately one week before surgery, a research assistant invited patients to participate in the study, but definitive recruitment with written informed consent was by the principal investigator. Randomisation to the two groups was implemented by the research assistant away from the study procedures using a computer-generated random number delivered to the study site in pre-prepared sealed opaque envelopes.
Study procedures
Intravenous sedation (up to midazolam 2 mg, alfentanil 0.5 mg) and cephazolin 1 g were administered approximately five minutes before block placement. All blocks were performed by a single experienced operator.
Spinal block: In either the lateral or sitting patient position, subarachnoid bupivacaine 0.5% 2 ml and preservative-free morphine 0.1 mg were administered using a 25G pencil point needle at the L3/4 or L4/5 interspace.
Lumbar plexus block: This was performed according to the technique described by Heller et al 8 . The skin and subcutaneous tissue in the lumbar paravertebral area were infiltrated to a depth of 5 cm using 10 ml 1% lignocaine with adrenaline (1/200,000). An 18G 10 cm insulated Tuohy needle (Contiplex® Tuohy, BBraun, Bethlehem, PA, USA) attached to a 10 ml 5% dextrose-filled syringe connected to a nerve stimulator (Pajunk Vario, Tucker, GA, USA) set at 1.5 mA (0.1 ms, 2 Hz) was inserted approximately one quarter of the distance along a line marked from the L3 spinous process to the posterior superior iliac spine. Needle advancement was through the subcutaneous tissue and then adjusted until the elicitation of an appropriate sustained quadriceps motor response at <0.8 mA. If a sustained motor response was present at <0.5 mA, the needle was manipulated until the response was eliminated.
Following confirmation of correct needle tip position, with the needle bevel facing laterally, and the pink needlecatheter guide sited within the needle hub, a non-stimulating catheter was blindly advanced several centimetres beyond the needle tip and then, after needle withdrawal, withdrawn until 3 cm of catheter remained past the original needle tip position (approximately eight to ten centimetres at the skin). The puncture site was sealed with 0.5 ml topical medical cyanoacrylate (Dermabond ® , Ethicon, San Angelo, TX, USA) and the catheter fixed to the skin with a locking device (Lockit-plus, Portex, Hythe, UK). A more detailed description and video of the technique can be found at www.ultrasoundblock.com. Slow fractionated injection with intermittent aspiration of 40 ml ropivacaine 0.5% was administered through the catheter.
Pre-and intraoperative management
Intravenous parecoxib 40 mg was administered at the time of surgery. All patients were given a standardised general anaesthetic using a laryngeal mask airway, volatile anaesthesia and spontaneous respiration (end-tidal minimum alveolar concentration = 0.8 to 1.2) Intraoperatively, patients in the lumbar plexus group were given intravenous morphine 0.1 mg/kg and both groups were given pro re nata alfentanil 0.25 mg if the respiratory rate was >25/minute.
Postoperative management
Patients reporting a numerical rating pain score (NRPS) >2 (0 to 10) on emergence in the post-anaesthesia care unit (PACU) were given intravenous morphine 2 mg every two to three minutes to achieve a NRPS ≤2. The lumbar plexus catheter was connected to an elastomeric infusion device (On-Q C-Block, Surgical Synergies, Auckland, New Zealand) containing ropivacaine 0.2%. This device delivers a continuous infusion of 5 ml/h and patient-controlled boluses of an additional 5 ml every hour (bolus flow rate = 150 ml/h). Postoperative oral paracetamol (1 g every six hours) and sustained-release diclofenac (75 mg every 12 hours) were given regularly. Sustained-release tramadol 100 mg every 12 hours was added for those patients who, despite regular paracetamol, diclofenac, and for the lumbar plexus group, ropivacaine boluses, had a NRPS >3. Potent opioid was administered if pain persisted despite tramadol (oral morphine for NRPS >3, intravenous morphine for NRPS >5).
Data collection
At the time of catheter insertion, the principal investigator recorded block placement time defined as the time from when the patient was positioned for block placement until block completion. Lower limb sensory and motor testing was not performed. During surgery, the principal investigator recorded the number of alfentanil boluses. The patient's primary PACU nurse recorded PACU pain and morphine consumption. All patients were visited in hospital by a research assistant on the afternoon of postoperative days one and two and questioned regarding numerically rated pain (0=no pain, 10=worst imaginable pain), numerically rated sleep (0=worst sleep, 10=best sleep) and the occurrence of pruritus and disorientation (yes/no). On postoperative day two, numerically rated satisfaction with the "pain relieving technique" (0 to 10, 0=very unsatisfied, 10=very satisfied) was assessed. A single physiotherapist recorded on day one and two whether the patient was able to transfer unassisted from bed-to-chair, bed-to-bath, perform a 12-metre walk, and the time to achieve that walk. After study completion, a research assistant reviewed all patient records to confirm morphine, tramadol and antiemetic consumption; arterial oxygen desaturation; and falls. Patients were contacted on day ten in regard to any new postoperative neurological symptoms.
Primary endpoint
The primary endpoint was 'worst pain' on movement during the first 24 postoperative hours (i.e. the patient's subjective assessment of their worst pain on movement at any time during this period).
Statistical analysis
Categorical outcomes were compared using Fisher's exact test (subjects requiring alfentanil, tramadol, and morphine; and complications). Non-normally distributed continuous variables (block placement time) and ordinal outcomes (all numerically rated outcomes) were compared using the Mann-Whitney U test. P-values of less than 0.05 were considered statistically significant. Two-sided tests were used for all experimental outcomes.
Other data were summarised using appropriate descriptive statistics (mean and standard deviation [SD] or mean and range for normally distributed or symmetric variables; median and interquartile ranges [IQR] for skewed variables; number and proportion for categorical variables). All statistical analyses were performed using Prism 5.0f (Graphpad software, La Jolla, CA, USA).
We originally planned to study 60 patients, however, due to slower than expected patient recruitment, the final sample size was revised to 50 patients, based on detection of a 2-point shift in day one numerically rated worst movement pain (0 to 10), an SD assumption of 2.5 points (based on the interquartile range reported by Ilfeld et al, and the estimate formula: SD=IQR/1.35) 5 , and 80% power (Student's t-test, Statmate 2.0; GraphPad, La Jolla, CA, USA).
Results
Fifty patients presenting for hip replacement were recruited during the study period: 23 were randomised to the spinal group and 27 to continuous lumbar plexus blockade. There were no patient and surgical characteristic differences between the two groups ( Table 1) . The primary outcome, worst pain on movement/mobilisation during the first 24 hours, was not significantly different between groups. Block placement time appeared marginally shorter for the spinal group (P=0.01) ( Table 1) . Patients in the lumbar plexus group appeared to require more intraoperative opioid and more morphine rescue in the PACU with correspondingly higher pain scores (Table 2 ). Subsequent pain scores during the first 24 hours appeared to be similar between groups; however, more patients in the spinal group required rescue morphine (5 versus 0, P=0.02). Pain scores and opioid supplementation did not statistically significantly differ between groups on day two. Physiotherapy mobilisation indices were also similar between groups. More of the spinal group patients reported pruritus (12 versus 0, P=0.01), but antiemetic requirements, episodes of disorientation, arterial oxygen desaturation and falls were all similar between groups ( Table 3 ). Symptoms suggestive of neurological irritation or injury did not differ between groups. All were mild and short-lived.
No patient demonstrated symptoms or signs of systemic local anaesthetic toxicity and there were no catheter-related bleeding or infectious complications. Values are n. cLPB=continuous lumbar plexus block.
Discussion
We compared spinal anaesthesia incorporating intrathecal morphine with continuous lumbar plexus blockade for analgesia after elective primary hip joint replacement. Spinal anaesthesia provided better analgesia in the PACU, but was associated with higher morphine requirements during the first 24 hours and more frequent pruritus. The two techniques were associated with similar indices for successful mobilisation and patient satisfaction.
Hip replacement is not associated with the same postoperative pain intensity as knee replacement. However, in the absence of a continuous regional block, an opioid requirement is typical during the first 24 hours 9 . This has led to the evaluation of opioid-sparing techniques. Continuous epidural block has been used historically and indeed provides effective analgesia following hip replacement, and may eliminate the requirement for systemic opioids. However, technical issues have been similar to those observed during knee replacement (contralateral leg weakness, technical catheter-related issues, logistical issues with concomitant thromboprophylaxis) 10, 11 and have consequently limited its popularity.
Local infiltration analgesia has become popular in some centres, all on the basis of observational studies and uncontrolled randomised studies lacking systemic administration of the infiltration components in controls e.g. adrenaline and ketorolac. Placebo-controlled trials are now emerging and are failing to confirm a significant benefit from the technique. When combined with spinal anaesthesia and multimodal analgesia incorporating a non-steroidal anti-inflammatory drug and gabapentin, high-volume local infiltration analgesia provided no advantage over placebo 12 . However, without multimodal analgesia, continuous epicapsular local anaesthetic has been shown to reduce pain and opioid consumption for up to 48 hours 13 .
Compared to opioid-only analgesia, single-shot lumbar plexus block has been shown to reduce intraoperative blood loss 1,10 , improve analgesia and reduce opioid consumption in the PACU for up to six postoperative hours 1 . When the technique is combined with a catheter, continuous lumbar plexus block has been shown to not only reduce pain and opioid consumption (especially during movement) 7 , but also reduce nausea and vomiting 4, 7 , improve patients' satisfaction and promote early mobilisation 7 . The latter has translated into reduced time to hospital discharge readiness by approximately one day 5 .
Spinal anaesthesia incorporating intrathecal morphine has also been used as a systemic opioid-sparing technique. It has been shown to provide better analgesia than single-injection lumbar plexus block during the first 24 hours, but is associated with a higher incidence of urinary retention (37% versus 11%) 3 despite optimisation of morphine dose (100 µg) 2, 14 . To date, intrathecal morphine has not been compared with continuous lumbar plexus blockade for hip replacement and this was the background for performing the present study.
Although many practitioners may consider subarachnoid blockade with intrathecal opioid to be a simple and effective technique for hip replacement, there are some patients in whom neuraxial anaesthesia is relatively contraindicated. The most common scenario are those patients with spinal stenosis. There is evidence that neurological complications from neuraxial anaesthesia (including spinal block) are more frequent in this patient group 15 , making lumbar plexus block a good alternative for pain management in these patients. Another issue with neuraxial analgesia is the epidural haematoma risk with concomitant perioperative thromboprophylaxis. However, there is an argument that, being a deep block and not amenable to external compression, lumbar plexus block should be treated with the same precautions as neuraxial blocks. This is a largely theoretical and unresolved issue, although intuitively, epidural haematoma is potentially more catastrophic than retroperitoneal haematoma. Lumbar plexus block is considered an advanced technique, anecdotally being associated with a relatively high risk of inadvertent intravascular injection, epidural spread and neurological complications. Compared to no block or a single-shot block, continuous lumbar plexus blockade might also increase the falls risk 16 . However, these risks may be successfully mitigated by appropriate patient and staff education e.g. preoperative education and supervised mobilisation. Lumbar plexus block will often not provide complete hip joint analgesia because of sciatic nerve-mediated pain, as demonstrated in the present study by the increased PACU opioid requirements. However, the present study suggests sciatic-mediated pain is only an issue for the first few hours postoperatively.
There is limited evidence that continuous femoral (anterior) blockade has an analgesic-and opioid-sparing effect after total hip joint replacement 7, 17 , but because of more reliable blockade of the obturator and lateral femoral cutaneous nerves, continuous (posterior) lumbar plexus block is a more effective analgesic technique for this surgery 7 .
The main limitation of the present study is the lack of observer blinding. Future studies should incorporate a sham lumbar plexus catheter with placebo infusion. Also, all secondary outcomes should be interpreted with caution and more 'exploratory', as power calculations were not performed on these outcomes.
Conclusion
Following elective total hip replacement, spinal anaesthesia with adjunctive intrathecal morphine provided better analgesia in the PACU than continuous lumbar plexus block. Lumbar plexus block, however, provided better subsequent analgesia over the first 24 hours and was associated with reduced pruritus. Each technique is a comparable alternative if one is contraindicated in any given patient.
